Croda’s Health Care division has become Croda Pharma, bringing its core specialty excipient portfolio together with the recent acquisition, Avanti Polar Lipids and its Adjuvant Systems arm, all under one business.    Croda Pharma has seen growth across its high purity excipients and vaccine adjuvants area and more recently announced the acquisition of Avanti Polar Lipids, bringing in a strong pipeline of novel lipids and formulation capabilities in-house.   The company continues to expand it...